Table 1.
Parameters required by the international IgA nephropathy prediction tool to predict 50% decline in eGFR or kidney failure up to 80 months from biopsy
| Parameters required by the IIgANPT |
|---|
| eGFR at biopsy |
| Systolic blood pressure at biopsy |
| Diastolic blood pressure at biopsy |
| Proteinuria at biopsy |
| Age at biopsy |
| Race |
| ACE inhibitor or ARB at biopsy |
| MEST scorea |
| Immunosuppression at or prior to biopsy |
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate; IIgANPT, international IgA nephropathy prediction tool.
a
MEST score refers to the Oxford Classification scoring for IgA nephropathy, excluding crescents: mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy/interstitial fibrosis (T).